NCT01312454View on ClinicalTrials.gov

Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412C

PHASE2TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Open-angle GlaucomaOcular Hypertension
Interventions
DRUG

AL-59412C injectable solution

Concentration 1 and Concentration 2

DRUG

Travoprost injectable solution

DRUG

AL-59412C Vehicle

Inactive ingredients used as placebo

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY